XH-002

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameXH-002
Drug Alias NameXH-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdatingSerine/threonine-protein kinase WEE1 inhibitors
TargetsSerine/threonine-protein kinase mTORPhosphatidylinositol 3 kinase beta
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInstitue Of Materia Medica Chinese Academy Of Medical Science
China Registration ClassN/A

Develop Information

Active CompaniesInstitue Of Materia Medica Chinese Academy Of Medical Science
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A